These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15592959)

  • 21. [Activity of the TNF-related apoptosis-inducing ligand gene expressed from the hTERT promoter on colon cancer cell line HT-29].
    Chen B; He C; Lao WF; Huang XF; Fang BL
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 35(1):45-9. PubMed ID: 16470920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
    Song Y; Shen K; He CX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases.
    Sova P; Ren XW; Ni S; Bernt KM; Mi J; Kiviat N; Lieber A
    Mol Ther; 2004 Apr; 9(4):496-509. PubMed ID: 15093180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells.
    Lin T; Huang X; Gu J; Zhang L; Roth JA; Xiong M; Curley SA; Yu Y; Hunt KK; Fang B
    Oncogene; 2002 Nov; 21(52):8020-8. PubMed ID: 12439752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytes.
    Armeanu S; Lauer UM; Smirnow I; Schenk M; Weiss TS; Gregor M; Bitzer M
    Cancer Res; 2003 May; 63(10):2369-72. PubMed ID: 12750253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer gene therapy using a novel secretable trimeric TRAIL.
    Kim CY; Jeong M; Mushiake H; Kim BM; Kim WB; Ko JP; Kim MH; Kim M; Kim TH; Robbins PD; Billiar TR; Seol DW
    Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The combination of TRAIL treatment and cancer cell selective expression of TRAIL-death receptor DR4 induces cell death in TRAIL-resistant cancer cells.
    Choi E; Kim Y; Kim K
    Yonsei Med J; 2006 Feb; 47(1):55-62. PubMed ID: 16502485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of patient tumor-derived colon cancer xenografts by a TRAIL gene-armed oncolytic adenovirus.
    Zhou W; Zhu H; Chen W; Hu X; Pang X; Zhang J; Huang X; Fang B; He C
    Cancer Gene Ther; 2011 May; 18(5):336-45. PubMed ID: 21183948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell to cell contact required for bystander effect of the TNF-related apoptosis-inducing ligand (TRAIL) gene.
    Huang X; Lin T; Gu J; Zhang L; Roth JA; Liu J; Fang B
    Int J Oncol; 2003 Jun; 22(6):1241-5. PubMed ID: 12738989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
    Ye X; Lu Q; Zhao Y; Ren Z; Ren XW; Qiu QH; Tong Y; Liang M; Hu F; Chen HZ
    Int J Mol Med; 2005 Dec; 16(6):1179-84. PubMed ID: 16273304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in mice.
    Zhang Y; Ma H; Zhang J; Liu S; Liu Y; Zheng D
    Life Sci; 2008 Jun; 82(23-24):1154-61. PubMed ID: 18485417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line.
    Zhang L; Gu J; Lin T; Huang X; Roth JA; Fang B
    Gene Ther; 2002 Sep; 9(18):1262-70. PubMed ID: 12215894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant adenoviruses expressing TRAIL demonstrate antitumor effects on non-small cell lung cancer (NSCLC).
    Yang F; Shi P; Xi X; Yi S; Li H; Sun Q; Sun M
    Med Oncol; 2006; 23(2):191-204. PubMed ID: 16720919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interleukin-12 enhanced tumor necrosis factor related apoptosis-inducing ligand TRAIL-induced apoptosis in human hepatocellular carcinoma by inhibiting expression of survivin].
    He SQ; Chen Y; Chen XP; Zhang WG; Wang HP; Zhang BX
    Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):453-7. PubMed ID: 12895357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis.
    Lanson NA; Friedlander PL; Schwarzenberger P; Kolls JK; Wang G
    Cancer Res; 2003 Nov; 63(22):7936-41. PubMed ID: 14633724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand.
    Reddy RM; Tsai WS; Ziauddin MF; Zuo J; Cole GW; Maxhimer JB; Fang B; Schrump DS; Nguyen DM
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):883-91. PubMed ID: 15573073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenovirus-mediated FLT1-targeted proapoptotic gene therapy of human prostate cancer.
    Kaliberov SA; Kaliberova LN; Stockard CR; Grizzle WE; Buchsbaum DJ
    Mol Ther; 2004 Dec; 10(6):1059-70. PubMed ID: 15564138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic antitumoral effects of human telomerase reverse transcriptase-mediated dual-apoptosis-related gene vector delivered by orally attenuated Salmonella enterica Serovar Typhimurium in murine tumor models.
    Fu W; Chu L; Han X; Liu X; Ren D
    J Gene Med; 2008 Jun; 10(6):690-701. PubMed ID: 18338832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cells.
    Yang Y; Xu H; Shen J; Yang Y; Wu S; Xiao J; Xu Y; Liu XY; Chu L
    Cell Death Dis; 2015 May; 6(5):e1760. PubMed ID: 25973680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice.
    Pei Z; Chu L; Zou W; Zhang Z; Qiu S; Qi R; Gu J; Qian C; Liu X
    Hepatology; 2004 May; 39(5):1371-81. PubMed ID: 15122766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.